(19)
(11) EP 1 365 645 A2

(12)

(88) Date of publication A3:
02.10.2003

(43) Date of publication:
03.12.2003 Bulletin 2003/49

(21) Application number: 01967934.9

(22) Date of filing: 21.06.2001
(51) International Patent Classification (IPC)7A01K 67/027, C07K 14/705, C07K 14/72, C07K 14/47, C12N 5/10, G01N 33/50
(86) International application number:
PCT/US0120/015
(87) International publication number:
WO 0109/8508 (27.12.2001 Gazette 2001/52)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 21.06.2000 US 213190 P
21.06.2000 US 213670 P
21.06.2000 US 213671 P
21.06.2000 US 214028 P
21.06.2000 US 213201 P
07.08.2000 US 223123 P
01.02.2001 US 266046 P
29.03.2001 US 280705 P
09.04.2001 US 282668 P
09.04.2001 US 282701 P

(71) Applicant: Deltagen, Inc.
Redwood City, CA 94063 (US)

(72) Inventors:
  • BRENNAN, Thomas, J.
    South San Francisco, CA 94080 (US)
  • LEVITEN, Michael, W.
    Palo Alto, CA 94306 (US)
  • KLEIN, Robert
    Palo Alto, CA 94301 (US)
  • MATTHEWS, William
    Woodside, CA 94062 (US)
  • MOORE, Mark
    Redwood City, CA 94062 (US)

(74) Representative: Furlong, Isla Jane 
D. Young & Co.21 New Fetter Lane
London EC4A 1DA
London EC4A 1DA (GB)

   


(54) TRANSGENIC MICE CONTAINING TARGETED GENE DISRUPTIONS